Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-60 (IGHV3-60) is a variable region gene segment found within the immunoglobulin heavy-chain locus in the human genome. The IGHV gene segments, including IGHV3-60, are rearranged during B cell development to generate the diverse antigen-binding specificity of antibodies. These gene segments contribute to the variable domain of the antibody heavy chain, pairing with a light chain variable domain to create the antigen recognition site[1][2]. However, IGHV3-60 is annotated as a pseudogene in major databases, indicating it is predicted to be nonfunctional in coding for a functional antibody variable domain protein in the reference human population[3]. As such, it does not operate as a functional protein, target, or biomarker. Notes and limitations: - IGHV3-60 is *not* a functional drug target or a standard receptor/enzyme. It is a nonfunctional pseudogene and should not be confused with similar-sounding active immunoglobulin variable gene segments. - No evidence supports drug interactions, utility as a diagnostic or therapeutic biomarker, or specific disease linkage beyond general immunogenetic diversity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-60 (IGHV3-60).